MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway

Non-small cell lung cancer (NSCLC) is the most common and lethal human malignant tumor worldwide. Platinum-based chemotherapy is still the mainstay of treatment for NSCLC. However, long-term chemotherapy usually induces serious drug resistance in NSCLC cells. Accordingly, treatment strategies that r...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Gang, Lou, Tianzheng, Pan, Jiongwei, Ye, Zaiting, Yin, Zhangyong, Li, Lu, Cheng, Wei, Cao, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503872/
https://www.ncbi.nlm.nih.gov/pubmed/30981205
http://dx.doi.org/10.18632/aging.101907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503872/
https://www.ncbi.nlm.nih.gov/pubmed/30981205
http://dx.doi.org/10.18632/aging.101907

Ejemplares similares